Case Report
CNS Involvement in a Patient with Chronic Myeloid Leukemia
Table 1
European Leukemia Network’ summary of the most appropriate alternative therapeutic options based on BCR-ABL KD mutation status [4].
| ||||||||||||||||
#Limited in vivo data suggest resistance to bosutinib in vivo in patients with E255K and, to a reduced extent, the E255V mutation. |